Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies
- PMID: 1757727
- DOI: 10.1007/BF02924248
Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies
Abstract
In this article, the effects of different classes of cholecystokinin (CCK) receptor antagonists in CCK-related physiological processes of the pancreas have been discussed. Both glutaramic acid derivatives and natural (benzodiazepine) analogs are potent, competitive antagonists of peripheral CCK receptors. These compounds thus provide a powerful tool for investigating the physiological and pharmacological actions of CCK in the gastrointestinal system, and have already clarified the role of CCK in pancreatic secretion and trophism or growth.
Similar articles
-
CCK regulates pancreatic enzyme secretion via short duodenal-pancreatic reflexes in pigs.Scand J Gastroenterol. 2003 Feb;38(2):201-6. doi: 10.1080/00365520310000708. Scand J Gastroenterol. 2003. PMID: 12678338
-
Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.Am J Physiol. 1989 Jul;257(1 Pt 1):G169-74. doi: 10.1152/ajpgi.1989.257.1.G169. Am J Physiol. 1989. PMID: 2473653
-
Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.Br J Pharmacol. 1998 Jun;124(3):435-40. doi: 10.1038/sj.bjp.0701811. Br J Pharmacol. 1998. PMID: 9647465 Free PMC article.
-
CCK receptor antagonists.Gen Pharmacol. 1998 Oct;31(4):519-24. doi: 10.1016/s0306-3623(98)00078-0. Gen Pharmacol. 1998. PMID: 9792209 Review.
-
Quantitative structure-activity relationship studies on cholecystokinin antagonists.Curr Pharm Des. 2002;8(2):111-24. doi: 10.2174/1381612023396500. Curr Pharm Des. 2002. PMID: 11812253 Review.
Cited by
-
Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.J Gastroenterol. 1996 Apr;31(2):249-53. doi: 10.1007/BF02389525. J Gastroenterol. 1996. PMID: 8680546
-
Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.Int J Pancreatol. 1997 Dec;22(3):177-85. doi: 10.1007/BF02788382. Int J Pancreatol. 1997. PMID: 9444548
-
Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion.Int J Pancreatol. 1993 Apr;13(2):129-37. doi: 10.1007/BF02786081. Int J Pancreatol. 1993. PMID: 8501354